Knockout of A3 adenosine receptors reduces mouse intraocular pressure

Investigative Ophthalmology and Visual Science

Volumn 43, Issue 9, 2002, Pages 3021-3026

  Avila, Marcel Y ^a   Stone, Richard A ^a   Civan, Mortimer M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIHYDRO 2 METHYL 6 PHENYL 4 (2 PHENYLETHYNYL) 3,5 PYRIDINEDICARBOXYLIC ACID 5 BENZYL 3 ETHYL ESTER; 6 ETHYL 4 PROPYL 2 PHENYL 3 PYRIDINECARBOXYLIC ACID 5 THIOCARBOXYLIC ACID 5 ETHYL 3 PROPYL ESTER; ACETAZOLAMIDE; ADENOSINE; ADENOSINE A3 RECEPTOR; ADENOSINE A3 RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG; ADENOSINE RECEPTOR; DIHYDROPYRIDINE DERIVATIVE; DRUG DERIVATIVE; EYE DROPS; N(6) (3 IODOBENZYL) 5' N METHYLCARBOXAMIDOADENOSINE; N(6)-(3-IODOBENZYL)-5'-N-METHYLCARBOXAMIDOADENOSINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; AQUEOUS HUMOR FLOW; AQUEOUS HUMOR FORMATION; ARTICLE; CONTROLLED STUDY; FEMALE; GLAUCOMA; INTRAOCULAR PRESSURE; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; C57BL MOUSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; MOUSE MUTANT; PHYSIOLOGY; TOPICAL DRUG ADMINISTRATION;

ADENOSINE; ADMINISTRATION, TOPICAL; ANIMALS; DIHYDROPYRIDINES; INTRAOCULAR PRESSURE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OPHTHALMIC SOLUTIONS; RECEPTOR, ADENOSINE A3; RECEPTORS, PURINERGIC P1;

EID: 0036707516     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Interacting loci cause severe iris atrophy and glaucoma in DBA/2J mice
2. Development of characterization of a immortal and differentiated murine trabecular meshwork cell line
3. Reliable measurement of mouse intraocular pressure by a servo-null micropipette system
4. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma
5. The Advanced Glaucoma Intervention Study (AGIS). 7: The relationship between control of intraocular pressure and visual field deterioration
6. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures
7. Intraocular volumes and surface area measurements of the mouse eye
8. A(1)-, A(2A)- and A(3)-subtype adenosine receptors modulate intraocular pressure in the mouse
9. Adenosine receptor activation modulates intraocular pressure in rabbits
10. Characterization of ocular hypertension induced by adenosine agonists
11. Effects of adenosine agonists on intraocular pressure and aqueous humor dynamics in cynomolgus monkeys
12. Intraocular pressure responses to the adenosine agonist cyclohexyladenosine: Evidence for a dual mechanism of action
13. Adenosine stimulates Cl- channels of nonpigmented ciliary epithelial cells
14. - channels of nonpigmented ciliary epithelial cells
15. Disruption of the A(3) adenosine receptor gene in mice and its effect on stimulated inflammatory cells
16. Adenosine and inosine increase cutaneous vasopermeability by activating A(3) receptors on mast cells
17. A role for the A3 adenosine receptor in determining tissue levels of cAMP and blood pressure: Studies in knock-out mice
18. Targeted deletion of A(3) adenosine receptors improves tolerance to ischemia-reperfusion injury in mouse myocardium
19. Targeted deletion of the A3 adenosine receptor confers resistance to myocardial ischemic injury and does not prevent early preconditioning
20. + exchange reduce mouse intraocular pressure
21. Sample size calculations for ophthalmologic studies
22. Molecular approach to adenosine receptors: Receptor-mediated mechanisms of tissue protection
23. Pharmacological characterization of novel A3 adenosine receptor-selective antagonists
24. Synthesis, CoMFA analysis, and receptor docking of 3,5-diacyl-2,4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists
25. Similarity of A(3)-adenosine and swelling-activated Cl(-) channels in nonpigmented ciliary epithelial cells
26. Activation of A(3) adenosine receptor induces calcium entry and chloride secretion in A(6) cells
27. Structure-activity relationships and molecular modeling of 3,5-diacyl-2,4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists
28. Pharmacological characterization of adenosine receptors in PGT-beta mouse pineal gland tumour cells